Table 1 The baseline characteristics of included studies
Study, year, country | Recipient sites | Follow-up (months) | VMM | No. of operations | Group | Number | Age, years | BMI | Gender, M/F | FSR, % | Satisfactory |
|---|---|---|---|---|---|---|---|---|---|---|---|
Tissiani LA, 2016, Brazil | Breast | 36 | MRI | 1 | SVF fat | 11 | 43–58 | 23.5–30.9 | 0/11 | 78.8 (74.9) | NR |
1 | Fat | 8 | 36–69 | 20.8–32.4 | 0/8 | 51.4 (18.4) | NR | ||||
Sasaki GH, 2015, USA | Face | 12 | Photography | 1 | SVF fat | 9 | 65.5 (52–77) | 22.0 (21.0–30.8) | NR | 72.9 (50.0) | NR |
1 | Fat | 92 | 60.5 (58–63) | 22.0 (19.9–24.2) | 38.3 (12.9) | NR | |||||
Zhao JH, 2014, China | Face | 14 | NA | 1 | BMSC fat | 10 | 25 (20–35) | NR | 3/7 | NR | 10 |
1 | Fat | 26 | 24 (18–38) | NR | 8/18 | NR | 24 | ||||
Tanikawa DY, 2013, Brazil | Face | 6 | CT | 1 | SVF fat | 7 | 12.1 ± 2.2 | < 25 | 2/5 | 88.0 (13.0) | 7 |
1 | Fat | 7 | 18.7 ± 7.6 | < 25 | 3/4 | 54.0 (20.0) | 3 | ||||
Peltoniemi HH, 2013, Finland | Breast | 6 | MRI | 1 | SVF fat | 10 | 51 (29–58) | 23.4 (20.3–32.5) | 0/10 | 50.0 (10.0) | NR |
1 | Fat | 8 | 39 (33–63) | 23.4 (20.3–25.9) | 0/8 | 54.0 (7.0) | NR | ||||
Li J, 2013, China | Face | 6 | CT | 1 | SVF fat | 26 | 29.5 ± 6.8 | NR | 0/26 | 64.8 (10.2) | NR |
1 | Fat | 12 | 29.1 ± 6.0 | NR | 0/12 | 46.4 (9.3) | NR | ||||
Kolle SF, 2013, Denmark | Arm | 4 | MRI | 1 | SVF fat | 10 | 28.4 ± 8.9 | 24.7 ± 2.0 | NR | 80.9 (6.0) | NR |
Fat | 10 | 16.3 (7.2) | NR | ||||||||
Chang Q, 2013, China | Face | 18 | CT | 2 in 30%, 3 in 20% | SVF fat | 10 | 27.5 (19–35) | NR | 8/12 | 68.3 (1.7) | NR |
Fat | 10 | 58.5 (1.3) | NR | ||||||||
Sterodimas A, 2011, Brazil | Face | 18 | NA | 1 | SVF fat | 10 | 43.9 (22–72) | NR | 3/7 | NR | 9 |
2 in 30%, 3 in 40% | Fat | 10 | 46.2 (25–70) | 2/8 | NR | 9 |